NCT06446232

Brief Summary

This project uses questionnaires to statistically analyze whether influenza vaccination is protective for young children.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
40mo left

Started Sep 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Sep 2023Aug 2029

First Submitted

Initial submission to the registry

June 27, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
9 months until next milestone

First Posted

Study publicly available on registry

June 6, 2024

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2029

Last Updated

June 6, 2024

Status Verified

June 1, 2024

Enrollment Period

5 years

First QC Date

June 27, 2023

Last Update Submit

June 5, 2024

Conditions

Influenza Vaccine Allergy

Keywords

Influenza Vaccine

Outcome Measures

Primary Outcomes (1)

  • Questionnaires

    This project uses questionnaires to statistically analyze whether the flu vaccine is protective for young children. Researchers collect flu rapid test results and invite subjects to write questionnaires. Data collectors administered a standardised questionnaire that included information on demographics, medical history (including flu vaccination status and self-reported prior flu infection).

    12 months

Eligibility Criteria

Age6 Months - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Those who have performed a rapid influenza screening test, regardless of whether the result is negative or positive

You may qualify if:

  • Clinical diagnosis of influenza by Flu A+B rapid antigen test
  • Known vaccination status

You may not qualify if:

  • Unknown vaccination status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Influenza, Human

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Central Study Contacts

Yi Jen Liau

CONTACT

02-23123456u8809032@gmail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2023

First Posted

June 6, 2024

Study Start

September 1, 2023

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

August 31, 2029

Last Updated

June 6, 2024

Record last verified: 2024-06

Locations

TW(1)